NOS3 and endothelial dysfunction: Secosterol A potently inhibits endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase (nNOS), but not iNOS [116], and should therefore make an important contribution to endothelial dysfunction and insulin resistance, since eNOS promotes insulin sensitivity while iNOS promotes insulin resistance in humans [117].